Bayer and Ginkgo Bioworks unveil joint venture, Joyn Bio, and establish operations in Boston and West Sacramento

Joyn Bio’s initial efforts focus on nitrogen fixation to enhance sustainability in agriculture / Researchers will broadly explore application of beneficial microbes to plants for next generation solutions to agriculture’s biggest challenges / Dr. Mike Miille appointed as CEO

Source: Bayer Company News - March 20, 2018 Category: Pharmaceuticals Source Type: news